Primary Record
Gianvi
- In stock
- 9,400 g
- Purity
- 98.4 %
- CAS
- 164017-31-6
Compound Identifiers & Properties
- CAS
- 164017-31-6
- PubChem CID
- 147740
- SMILES
- C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C.C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O
- Canonical SMILES
- C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C.C[C@]12CCC(=O)C=C1[C@@H]1C[C@@H]1[C@H]1[C@@H]3[C@@H]4C[C@@H]4[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@@H]12
Names & Synonyms
- Gianvi
- Yasmin
- Vestura
- Loryna
- Ocella
- Nikki
- Syeda
- Zarah
- Zumandimine
- Petibelle
- Yvidually
- Jasmiel
- Lo-Zumandimine
- Yasmin 28
- Drospirenone(DRSP)
- KEMEYA
- KYRA
- MELAMISA
- YAELA
- Drospirenone/Ethinyl Estradiol
- Drospirenone and estradiol
- Yaz-28
- EE20/DRSP
- Drospirenone; ethinyl estradiol
- RefChem:934399
- Drospirenone-ethinylestradiol mixt
- Ethinylestradiol-drospirenone mixt
- AC1L3VT1
- Drospirenone mixture with Ethinylestradiol
- orb1986095
- SCHEMBL8464101
- SCHEMBL29367672
- Drospirenone & Ethinyl Estradiol
- DTXSID80936898
- DR1021
- Drospirenone and Ethinyl Estradiol
- Ethinylestradiol mixture with drospirenone
- 164017-31-6
- Drospirenone mixture with Ethinyl estradiol
- BAY 86-5300
- CID147740
- AKOS040751644
- C24H30O3.C20H24O2
- drospirenone and ethinyl estradiol combination
- Drospirenone and Ethinyl Estradiol Tablets
- LS-181813
- C24-H30-O3.C20-H24-O2
- Z 30.595
- (1R,2R,4R,10R,11S,14S,15S,16S,18S,19S)-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-15,5'-oxolane]-2',7-dione;(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- YAZ
- 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-, mixt. with (2'S,6R,7R,8R,9S,10R,13S,14S,15S,16S)-3',4',6,7,8,9,10,11,12,13,14,15,16,20,21-hexadecahydro-10,13-dimethylspiro(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione
- (1aR,2'S,5aR,5bS,7aS,8aS,9aS,9bS,9cR,9dR)-5a,7a-Dimethyl-1,1a,5,5a,5b,6,7,7a,8a,9,9a,9b,9c,9d-tetradecahydrospiro[cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-8,2'-oxolane]-3,5'(4H)-dione--17alpha-19-norpregna-1(10),2,4-trien-20-yne-3,17-diol (1/1)
- (4aR,4bS,6aS,7S,7aS,8aS,8bS,8cR,8dR,9aR)-4a,6a-dimethyl-3',4,4a,4b,4',5,6,6a,7a,8,8a,8b,8c,8d,9,9a-hexadecahydro-5'H-spiro[cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-7,2'-furan]-2,5'(3H)-dione compound with (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol (1:1)
- 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol,(17alpha)-,mixt.w/(2'S,6R,7R,8R,9S,10R,13S,14S,15S,16S)-3',4',6,7,8,9,10,11,12,13,14,15,16,20,21-hexadecahydro-10,13-dimethylspiro(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione
- 5a,7a-Dimethyl-1,1a,5,5a,5b,6,7,7a,8a,9,9a,9b,9c,9d-tetradecahydrospiro[cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-8,2'-oxolane]-3,5'(4H)-dione--19-norpregna-1(10),2,4-trien-20-yne-3,17-diol (1/1)